Correction {#Sec1}
==========

In the publication of this article \[[@CR1]\], there was an error in the Methods, Cell cultures and reagents section: the Methods, Cell cultures and reagents section: 'The following primary antibodies were used: P62(\#8025), phospho-H2AX(γ-H2AX;\#9718), caspase-8(\#9746), RIP1(\#3493s), Beclin1(3738s), ATG7 (\#2631S), PARP (\#9546S), caspase-3(\#9665s), cIAP1 (\#7065s), cIAP2(3130s), XIAP(\#14334), FADD(\#2782S), phospho-NF-κBp105/p50(4806S), NF-κB2p100/p52(\#4882S) and TNFR1(\#3736S) were purchased from Cell Signaling Technology Inc.; GAPDH (\#sc-47724) from Santa Cruz Biotechnology (SC); LC3 (\#NB100--2220) from Novus Biologicals'.

Should instead read: 'The following primary antibodies: P62 (\#8025), phospho-H2AX (γ-H2AX;\#9718), caspase-8 (\#9746), RIP1 (\#3493s), Beclin1 (3738s), ATG7 (\#2631S), PARP (\#9546S), caspase-3 (\#9665s), cIAP1 (\#7065), cIAP2 (3130s), XIAP (\#14334), FADD (\#2782S), NF-κBp105/p50 (4806S), NF-κB2p100/p52 (\#4882S), TNF-α (\#6945s), TNF-α neutralizing antibody (7321s), and TNFR1 (\#3736S) were purchased from Cell Signaling Technology Inc.; GAPDH (\#sc-47724) was from Santa Cruz Biotechnology (SC); LC3 (\#NB100--2220) was from Novus Biologicals. Z-VAD-FMK (\#V116) and Necrostatin-1(\#N9037) were from Sigma. IKK-16(\#S2882) from Selleck'.

In the Results, APG-1387 is RIP1-dependent in ovarian cancer induced apoptosis section there was an error: 'We examined the protein levels of caspase-8/RIP1 by western blot, as shown in Fig. 4a'.

Should instead read: 'We examined the protein levels of caspase-8/RIP1 by western blot. APG-1387 triggered the activation of caspase-8 and downregulated the protein level of RIP1, as shown in Fig. 4a'.

In the Results, APG-1387 induces apoptotic cell death through engagement of TNFR1 by TNF-alpha signaling pathway section there was an error: 'We have investigated the expression of NF-κB1/p50 and NF-κB2/p52 by western blot after cells were incubated with various concentrations of APG-1387'.

Should instead read: 'These results demonstrate that TNFα signaling is required for APG-1387-induced apoptotic cell death. Next, we have investigated the expression of NF-κB1/p50 and NF-κB2/p52 by western blot after cells were incubated with various concentrations of APG-1387'.

A section header contained an error: 'APG-1387-induced autophagy'

Should instead read: 'APG-1387 induces autophagy in ovarian cancer'

A section header contained an error: 'APG-1387-induced apoptosisby modulating autophagy'

Should instead read: 'Inhibition of autophagy sensitizes ovarian cancer cells to A PG-1387-induced apoptosis'.

In the Discussion section there was an error: 'APG-1387 is a novel Smac mimetic. In our study, we investigated the molecular mechanisms underlying the inhibitory effect on the growth of ovarian cancer cell lines treated with varying concentrations of APG-1387'.

Should instead read: 'Restoring the apoptotic cell death machinery by pharmacological inhibition of IAPs proteins represents a compelling strategy for cancer therapy. APG-1387 is a novel Smac mimetic developed by Ascentage and currently being evaluated in phase I clinical trial. In our study, we investigated the in vitro and in vivo antitumor activity of APG-1387 in ovarian cancer'.

In the Discussion section there was an error: 'Our results suggest that APG-1387 induces autophagy during apoptosis. Autophagy plays a role in protecting cell survival. We have also found that it was effective as a single agent in vivo models. Treatment with APG-1387 induced potent cytotoxic and anti-proliferative activity against established and human ovarian cancer cells'.

Should instead read: 'Our results suggest that APG-1387 induces autophagy while triggering apoptosis. APG-1387-induced autophagy plays a role in protecting cell survival and inhibition of autophagy potentiates cytotoxicity of APG-1387 in ovarian cancer cells'.

Figure 7 caption had an an error: 'APG-1387-induced autophagy promote cell death in SKOV3 cells'.

Should instead read: 'Fig. 7 APG-1387-induced autophagy promotes cell survival in SKOV3 cells'.

In the Funding section there was an error due to the fact some additional funds were missing.

Should instead additionally read: 'the Project of International Science and Technology Cooperation of Fujian Province (Grant number. 2015I0002); and the Joint Funds for the innovation of science and Technology, Fujian province (Grant number. 2016Y91030065). The correct Figs. [2](#Fig1){ref-type="fig"}, [3](#Fig2){ref-type="fig"} and [6](#Fig3){ref-type="fig"} are presented here:Fig. 2Effects of APG-1387 on apoptosis in ovarian cancer. **a** APG-1387 inhibited the proliferation of SKOV3 cell line. They were treated with the indicated concentrations of APG-1387 for 24, 48, 72 h. Cell viability was determined by the CCK-8 assay. **b** Morphology of SKOV3 cells exposed to APG-1387(0, 10 nM) photographed under a fluorescence microscope (original magnification× 10). **c** APG-1387-induced apoptosis in SKOV3 cells was assessed by Hoechst33258 staining. Morphology of SKOV3 cells exposed to APG-1387 at different concentrations photographed under a fluorescence microscope (original magnification × 10). Condensated and fragmented nuclears were the mean ± SEM of 5 randomized areas. *P* \< 0.01. **d** SKOV3 cells were treated with 10 nM APG-1387 for the indicated times. The cells were stained for phosphorylated H~2~AX and DAPI, then were analyzed by fluorescence microscopy (original magnification × 200). γ-H~2~AX positive spots were the mean ± SEM of 5 randomized areas. *P* \< 0.01. **e**, **f** SKOV3 and OVCAR3 cells were exposed to various concentrations of APG-1387 (0, 10, 30 nM) for 24 h followed cell apoptosis analysis by flow cytometry. **g** Western blot analysis of caspase-3/PARP SKOV3 cells were treated withAPG-1387 (0, 3, 10, 30, 100, 300 nM) for 24 h. The data shown are representative of three different experiments. **h** SKOV3 cells were stimulated with APG-1387 for indicated periods of concentrations, caspase activation were tested by caspase activity assayFig. 3APG-1387-induced apoptosis in caspase dependent manner. **a** Cells with or without addition of Z-VAD-FMK. Morphology of cells exposed to different treatment groups photographed under a fluorescence microscope (original magnification × 10). **b** APG-1387 was coadministered with or without addition of caspase inhibitor (Z-VAD-FMK). Cell viability was determined by the CCK-8 assay. **c** Western blot analysis of the effect of APG-1387 with or without addition of Z-VAD-FMK on caspase-3/PARP expression level in SKOV3 cells. **d** Western blot analysis of the expression levels of IAPs at different concentrations of APG-1387 in SKOV3 cells. **e** Cells were treated with different time points, and the effect of APG-1387 on IAP family members expression level was determined by western blot. Data represent one of three experiments yielding similar resultsFig. 6APG-1387 induces autophagy in ovarian cancer cells. **a** The expression of LC3, Beclin1 and P62 was measured by western blot. Cells were treated with APG-1387(0, 3, 10, 30, 100, 300 nM) for 24 h. **b** Cells were transfected with GFP-LC3 plasmids, and then maintained in media with or without 3 nM APG-1387 for 24 h. The cells were then stained with DAPI and analyzed by fluorescence microscopy. **c** Statistical analysis of the percentage of LC3 puncta per cell. Columns, mean (*n* = 3); bars, SD. \**P* \< 0.01 vs. untreated group. LC3 puncta per cell were quantified. **d** Cells were transfected with Beclin1 siRNAs. Western blot was used to detect the expression of Beclin1. **e** Cells were transfected with ATG7 siRNAs. Western blot was used to detect the expression of ATG7. **f** Cells were transfected with Beclin1 siRNAs. After 24 h treatment with or without 3 nM APG-1387, western blot analysis was performed for indicated proteins. **g** Cells were transfected with ATG7 siRNAs. After 24 h treatment with or without 3 nM APG-1387, western blot analysis was performed for indicated proteins. **h** Western blot analysis was performed for indicated proteins in cells transfected with siBeclin-1 and treated with 10 nM APG-1387. **i** Western blot analysis was performed for indicated proteins in cells transfected with siATG7--1 and treated with 10 nM APG-1387

This has now been updated in the original article \[[@CR1]\].

The original article can be found online at 10.1186/s13046-018-0703-9
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